STAFF

Dr. Juan Alberto Falcó Graciá

Senior researcher, Universidad Miguel Hernández

 

]

Unit
Molecular and Cellular Design

^

Subunit
Design and validation of nanostructures

Group
Fish biomedical nanoapplications

+34 966 658 744

Alberto Falcó Graciá

ResearchGate
Alberto Falcó Graciá

RESEARCH FIELDS 

  • Study of animal mucosa bioactive compounds.
  • Nanostructures for biomedical and veterinary skin applications. 
  • Evolutionary studies on short pentraxins (CRP and SAP).

PROFESSIONAL BACKGROUND

  • Previous positions:
    1.     Predoctoral fellow researcher (FPU) in Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Spain, 2003-2006.
  • Postdoctoral positions:
    1. Postdoctoral researcher (CGBEDSON S.L.), Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Spain, 2006-2008.
    2.     Postdoctoral researcher (Consolider Ingenio), Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Spain, 2008-2009.
    3. Postdoctoral fellow researcher (Marie Curie ITN), School of Life Sciences, Keele University, United Kingdom, 2009-2011.
    4. Postdoctoral fellow researcher (Marie Curie IEF), Department of Animal Sciences, Wageningen University, The Netherlands, 2011-2013.
    5. Postdoctoral researcher (HIPRA S.L.), Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Spain, 2014-2018.
    6. Postdoctoral researcher, Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche, Universidad Miguel Hernández, Spain, 2019.
    7. Senior researcher (RETOS-JIN), Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche, Universidad Miguel Hernández, Spain, 2019-present.
  • PhD in Molecular Biology, Universidad Miguel Hernández (2008), supervised by Drs. Mª Amparo Estepa Pérez and Julio Coll Morales.
  • Degree in Biology (2002), Universidad de Alicante.

 

FALCÓ-GRACIÁ, A.

REPRESENTATIVE PUBLICATIONS

Belló-Pérez, M., et al. (2020)

Scientific Reports, DOI: 10.1038/s41598-020-57501-0

Zebrafish C-reactive protein isoforms inhibit SVCV replication by blocking autophagy through interactions with cell membrane cholesterol.

 

Falco, A., et al. (2019)

Marine Drugs., DOI:  10.3390/md17020087

Antiviral activity of a turbot (scophthalmus maximus) NK-Lysin peptide by inhibition of low-pH virus-induced membrane fusion.

 

Martínez-Ortega, L., et al. (2019)

Pharmaceutics, DOI: 10.3390/pharmaceutics11010014

Development of a new delivery system based on drug-loadable electrospun nanofibers for psoriasis treatment.

 

Belló-Pérez, M., et al. (2018)

Drug Design, Development and Therapy, DOI:  10.2147/DDDT.S171087

Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV).

 

Mira, A., et al. (2017)

Scientific Reports, DOI: 10.1038/s41598-017-17542-4

Poly(methyl vinyl ether-alt-maleic acid) and ethyl monoester as building polymers for drug-loadable electrospun nanofibers.

 

Espín-Palazón, R., et al. (2016)

PLoS Pathogens, DOI: 10.1371/journal.ppat.1005699

TNFα Impairs Rhabdoviral Clearance by Inhibiting the Host Autophagic Antiviral Response.